Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical EfficacyHoyoung Maeng, Jay A. Berzofsky, Hadi Bagheri et al.|Frontiers in Oncology|2021Cited by 26
Identification of actionable targets for breast cancer intervention using a diversity outbred mouse modelJennifer B. Jacob, Wei‐Zen Wei|iScience|2023Cited by 7